Ranch buildings and open prairie in Oklahoma

Brady Clark, 8, Loves Hunting, Fishing and Ranching. His Oklahoma Mom Says the SMA Gene Therapy He Got at 14 Months Halted the Disease.

Ask 8-year-old Brady Clark what he loves, and the answer comes fast: hunting, fishing and ranching. His mother, Nicole Clark of Caddo, Oklahoma, remembers a time when that future was not certain. Around 9 months old, Brady began losing strength in his hands, could not stand up properly and was losing the ability to crawl. He was diagnosed with spinal muscular atrophy, or SMA, and at 14 months he received a one-time gene therapy called Zolgensma. “What that drug does is it stops the progression of the disease,” Clark told KTEN News.

Now Clark and another Caddo mother, whose son has the same disease, are speaking out together to spread awareness of what SMA looks like.

A Baby Who Was Losing Skills

Clark noticed early that Brady was regressing. At about 9 months, she said, he was losing the ability to do a lot of things. His hands were getting weaker. He could not stand up properly. Crawling was slipping away. The family realized something was wrong.

The National Institute of Neurological Disorders and Stroke describes SMA as a group of inherited diseases that damage motor neurons, the nerve cells that control movement, including the muscles used to breathe, swallow and walk. In one form, usually noticed between 6 and 18 months, children can sit without support but cannot stand or walk without help.

The Treatment at 14 Months

Brady received Zolgensma at 14 months. The Food and Drug Administration approved the gene therapy on May 24, 2019, for children under 2. It is given once, through a vein, with the dose based on weight. In approving it, the agency called SMA “a leading genetic cause of infant mortality.”

The NINDS says treatment early in life tends to provide more benefit than treatment later. The institute also lists two other approved drugs, nusinersen, given through a lumbar puncture, and risdiplam, taken by mouth, and notes that none of the treatments is a cure.

Brady still lives with the effects of the disease. “He just tires very, very fast,” his mother said. But the diagnosis has not slowed him down, KTEN reported, and what made that possible for Brady was treatment.

Why the Price Tag Matters

Not every family can get Zolgensma easily, KTEN reported, because it is expensive. Alissa Winters, the other Caddo mother in the story, cited a cost of $2.2 million and said the price keeps some families from getting treatment their children need to survive.

Winters’ son, Ryland, was diagnosed with SMA through his newborn screening. Local businesses in Durant are holding a benefit on Saturday, Nov. 21, for Ryland’s treatments, and a GoFundMe has raised thousands of dollars for the family. Winters told the station that seeing Brady, and everything he can do, gives her hope for her own son.

How SMA Is Found Earlier Now

Ryland’s diagnosis shows how SMA is often caught today. The disease is on the federal Recommended Uniform Screening Panel, the list of conditions the Health Resources and Services Administration advises states to screen newborns for.

SMA is inherited in an autosomal recessive pattern, meaning both copies of the SMN1 gene carry changes, according to MedlinePlus Genetics, which estimates it affects 1 in 8,000 to 10,000 people worldwide. KTEN, citing the National Library of Medicine, put it at about 1 in 14,654 newborns.

Parent Diaries has covered other families chasing gene therapies for rare conditions, including the mother of a 5-year-old with childhood dementia.

Two Families, One Diagnosis

Brady was diagnosed after symptoms appeared and treated at 14 months. Ryland was flagged by a screening test as a newborn. The two families have formed a bond, and their mothers are telling their stories together so other parents know the signs, and know that a child like Brady can grow up hunting, fishing and working a ranch.

This article was produced with AI assistance and edited for accuracy against the sources linked above.

Image: Dorkmo – CC0/Wikimedia Commons

Similar Posts